also observed in ovarian cancer research that MUC16 activates neutrophils’ Siglec-9 receptors, inducing inflammatory and immunosuppressive characteristics in these cells and weakening NK cells’ killing ability, collectively promoting tumor immune evasion (79). Here, MUC16 is linked to neoplasm.